From 24/7 Wall St. · Vandita Jadeja · · 50s
JNJ Stock Targeted for 15.57% Upside
JNJ stock could rise 15.57% to $291.60 by 2030, with analysts bullish despite recent quarterly miss.
In brief
JNJ stock could rise 15.57% to $291.60 by 2030, with analysts bullish despite recent quarterly miss. JNJ stock targets $291.60 in 12 months with 15.57% upside from current price of $252.32. Originally reported by 24/7 Wall St..
JNJ Quarterly Results
JNJ reported third-quarter results with 6% sales growth to $25.4 billion and adjusted EPS of $2.59.
Price Target Analysis
24/7 Wall St. targets $291.60 for JNJ stock, representing 15.57% upside from current price of $252.32.
Dividend Strength
JNJ offers 1.99% dividend yield and 64 consecutive years of dividend increases.
Oncology Growth
Oncology business growing at double-digit pace with TREMFYA up 68.2% and potential $10 billion franchise.
MedTech Performance
MedTech grew 2.5% in Q3 but shares fell after device sales miss.
Analyst Ratings
16 analysts rate JNJ a Buy or Strong Buy with 90% confidence in target.
The key point
JNJ stock targets $291.60 in 12 months with 15.57% upside from current price of $252.32.
